NM_015158.5:c.-84+61163T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015158.5(KANK1):​c.-84+61163T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 152,110 control chromosomes in the GnomAD database, including 10,042 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 10042 hom., cov: 32)

Consequence

KANK1
NM_015158.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.214

Publications

4 publications found
Variant links:
Genes affected
KANK1 (HGNC:19309): (KN motif and ankyrin repeat domains 1) The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
KANK1 Gene-Disease associations (from GenCC):
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 2
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015158.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
NM_015158.5
MANE Select
c.-84+61163T>C
intron
N/ANP_055973.2
KANK1
NM_001256876.3
c.-84+25250T>C
intron
N/ANP_001243805.1
KANK1
NM_001256877.3
c.-84+16196T>C
intron
N/ANP_001243806.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
ENST00000382297.7
TSL:1 MANE Select
c.-84+61163T>C
intron
N/AENSP00000371734.2
KANK1
ENST00000382303.5
TSL:1
c.-84+25250T>C
intron
N/AENSP00000371740.1
KANK1
ENST00000619269.5
TSL:5
c.-84+61163T>C
intron
N/AENSP00000477725.2

Frequencies

GnomAD3 genomes
AF:
0.352
AC:
53435
AN:
151992
Hom.:
10021
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.462
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.454
Gnomad ASJ
AF:
0.215
Gnomad EAS
AF:
0.322
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.318
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.288
Gnomad OTH
AF:
0.332
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.352
AC:
53495
AN:
152110
Hom.:
10042
Cov.:
32
AF XY:
0.352
AC XY:
26152
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.462
AC:
19167
AN:
41470
American (AMR)
AF:
0.455
AC:
6952
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
745
AN:
3468
East Asian (EAS)
AF:
0.322
AC:
1665
AN:
5178
South Asian (SAS)
AF:
0.198
AC:
957
AN:
4822
European-Finnish (FIN)
AF:
0.318
AC:
3368
AN:
10596
Middle Eastern (MID)
AF:
0.313
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
0.288
AC:
19553
AN:
67974
Other (OTH)
AF:
0.336
AC:
711
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1692
3383
5075
6766
8458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0598
Hom.:
1468
Bravo
AF:
0.369
Asia WGS
AF:
0.325
AC:
1129
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.9
DANN
Benign
0.34
PhyloP100
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7027930; hg19: chr9-565917; API